OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery
Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114849-114849
Closed Access | Times Cited: 17
Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114849-114849
Closed Access | Times Cited: 17
Showing 17 citing articles:
Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke
Lukui Chen, Zhihan Zhu, Jia Feng, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 2, pp. 404-404
Open Access | Times Cited: 71
Lukui Chen, Zhihan Zhu, Jia Feng, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 2, pp. 404-404
Open Access | Times Cited: 71
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 20
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 20
Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review
Manash Pratim Pathak, Kalyani Pathak, Riya Saikia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112901-112901
Open Access | Times Cited: 51
Manash Pratim Pathak, Kalyani Pathak, Riya Saikia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112901-112901
Open Access | Times Cited: 51
3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy
Hellen Windolf, Rebecca Chamberlain, Jörg Breitkreutz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 931-931
Open Access | Times Cited: 38
Hellen Windolf, Rebecca Chamberlain, Jörg Breitkreutz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 931-931
Open Access | Times Cited: 38
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy
Dharmendra Kumar Khatri, Preeti Kumari, Shivraj Tonape, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 493-516
Open Access | Times Cited: 38
Dharmendra Kumar Khatri, Preeti Kumari, Shivraj Tonape, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 493-516
Open Access | Times Cited: 38
Levodopa-loaded nanoparticles for the treatment of Parkinson's disease
Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 212-224
Open Access | Times Cited: 29
Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 212-224
Open Access | Times Cited: 29
Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence
Ritam Bandopadhyay, Nainshi Mishra, Ruhi Rana, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Ritam Bandopadhyay, Nainshi Mishra, Ruhi Rana, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models
Dewei He, Shoupeng Fu, Bojian Ye, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Dewei He, Shoupeng Fu, Bojian Ye, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms
Mary Dayne Sia Tai, Gloria Gamiz-Arco, Aurora Martı́nez
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1275-1291
Open Access | Times Cited: 5
Mary Dayne Sia Tai, Gloria Gamiz-Arco, Aurora Martı́nez
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1275-1291
Open Access | Times Cited: 5
Optimization of Pramipexole-Loaded In Situ Thermosensitive Intranasal Gel for Parkinson’s Disease
Rushi Trivedi, Vahid Vikram Minglani, Ahmed M. El‐Gazzar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 172-172
Open Access | Times Cited: 4
Rushi Trivedi, Vahid Vikram Minglani, Ahmed M. El‐Gazzar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 172-172
Open Access | Times Cited: 4
Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes
Irfan Ali, Mohammad Adil, Mohammad Imran, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Irfan Ali, Mohammad Adil, Mohammad Imran, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Recent Advances in Rotigotine Nanoformulations for Parkinson’s Disease Therapy
Sanchit Arora, Dalapathi Gugulothu
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
Sanchit Arora, Dalapathi Gugulothu
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research
Mohammad Ahmed Khan, Nafis Haider, Tanveer Singh, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 3, pp. 873-919
Closed Access | Times Cited: 8
Mohammad Ahmed Khan, Nafis Haider, Tanveer Singh, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 3, pp. 873-919
Closed Access | Times Cited: 8
Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease
Neha Kanojia, Komal Thapa, Gagandeep Kaur, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104074-104074
Closed Access | Times Cited: 12
Neha Kanojia, Komal Thapa, Gagandeep Kaur, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104074-104074
Closed Access | Times Cited: 12
Novel drug delivery system in the management of Parkinson’s disease
Atul Kabra, Ritika Puri, Pradeep Goyal, et al.
Elsevier eBooks (2024), pp. 185-198
Closed Access
Atul Kabra, Ritika Puri, Pradeep Goyal, et al.
Elsevier eBooks (2024), pp. 185-198
Closed Access
Potential Neuroprotective Effect of Artemisinin in a Rotenone-induced Mice Model of Parkinson’s Disease
Nada M. Hamada, Hanan Eissa, Nirmeen Megahed, et al.
Mansoura Medical Journal (2023) Vol. 52, Iss. 2
Open Access
Nada M. Hamada, Hanan Eissa, Nirmeen Megahed, et al.
Mansoura Medical Journal (2023) Vol. 52, Iss. 2
Open Access
Drug Delivery Strategies in Parkinson’s Disease
Gurpreet Singh, Anupama Sikder, Shashi Bala Singh, et al.
(2023), pp. 305-324
Closed Access
Gurpreet Singh, Anupama Sikder, Shashi Bala Singh, et al.
(2023), pp. 305-324
Closed Access
